AN OPEN LABEL EXTENSION STUDY TO INVESTIGATE THE LONG TERM SAFETY, TOLERABILITY AND EFFICACY OF PF-02545920 IN SUBJECTS WITH HUNTINGTON’S DISEASE WHO PREVIOUSLY COMPLETED STUDY A8241021

Update Il y a 4 ans
Reference: U1111-1162-4293

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

- To assess long-term safety and tolerability of 20 mg BID of PF-02545920 in subjects with HD.


Inclusion criteria

  • Huntington's disease

Links